Citação norma APA

Vysotskaia, V., Kaseniit, K. E., Bucheit, L., Ready, K., Price, K., & Johansen Taber, K. (2019). Clinical utility of hereditary cancer panel testing: Impact of PALB2, ATM, CHEK2, NBN, BRIP1, RAD51C, and RAD51D results on patient management and adherence to provider recommendations. Cancer.

Citação norma Chicago

Vysotskaia, Valentina, K. Eerik Kaseniit, Leslie Bucheit, Kaylene Ready, Kristin Price, and Katherine Johansen Taber. "Clinical Utility of Hereditary Cancer Panel Testing: Impact of PALB2, ATM, CHEK2, NBN, BRIP1, RAD51C, and RAD51D Results On Patient Management and Adherence to Provider Recommendations." Cancer 2019.

Citação norma MLA

Vysotskaia, Valentina, et al. "Clinical Utility of Hereditary Cancer Panel Testing: Impact of PALB2, ATM, CHEK2, NBN, BRIP1, RAD51C, and RAD51D Results On Patient Management and Adherence to Provider Recommendations." Cancer 2019.

Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.